Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Saint-Leonard, Canada Clinical Trials

A listing of Saint-Leonard, Canada clinical trials actively recruiting patients volunteers.

RESULTS

Found (919) clinical trials

Cardiac Sarcoidosis Multi-Center Prospective Cohort

Baseline assessment of Clinically Manifest CS patients consists of: history, echocardiogram, ECG, chest CT scan, FDG-PET scan, blood for biomarkers within 2 months of the PET scan, cardiac MRI and possibly a signal average ECG and biopsy (encouraged-either endomyocardial or extra-cardiac). Follow-up and clinical management of clinically manifest patients diagnosed ...

Phase N/A

1.27 miles

Learn More »

Clinical Monitoring Strategy vs EP-guided Algorithmic in LBBB Patients Post-TAVI

The study population consists of pacemaker-free patients that are 18 years or older undergoing a TAVI with new onset left bundle branch block. Patient consent is required. Patients meeting the inclusion criteria will be randomized in a 1:1 ratio to one of the following two groups: Group 1: electrophysiology-based algorithmic ...

Phase N/A

1.27 miles

Learn More »

Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED

Background: Atrial fibrillation (AF) is characterized by disorganized atrial electrical depolarization leading to an irregular and rapid heart rate and is the most common arrhythmia seen in the emergency department (ED). Atrial flutter (AFL) is a less common arrhythmia with similar pathophysiology. Investigators will focus on recent-onset episodes of AF ...

Phase N/A

1.27 miles

Learn More »

Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

The REFINE ICD trial will assess whether prophylactic ICD therapy, guided by non-invasive risk assessment tools, reduces mortality in MI survivors with better-preserved LV function.

Phase

1.27 miles

Learn More »

The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial

Introduction Despite the widespread use of pharmacological and/or interventional reperfusion therapies, recovery of cardiac function in myocardial infarction patients is often modest or in some cases absent. Unlike classical re-perfusion therapies, which must be delivered before irreversible cardiac damage has occurred, the use of progenitor cells could potentially restore functional ...

Phase

1.27 miles

Learn More »

Advance Care Planning (ACP) in Elderly Cardiac Surgery Patients

Study Procedures: Once patients have signed an informed consent they will be asked to complete the ACP evaluation questionnaire. Their level of frailty will be assessed with the 5-meter walk test. Two weeks after discharge (+ or - 7 days) they will be contacted by phone in order to complete ...

Phase N/A

1.27 miles

Learn More »

Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy

The first and foremost manifestation of ischemic heart disease (IHD) is angina. At a global level, patients with chronic angina are at risk of poor vital status and deconditioning. Medical therapy and coronary revascularization using coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI) can effectively relieve angina . ...

Phase N/A

1.27 miles

Learn More »

A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)

Subjects will be asked to participate in an optional kinetics study. Subjects who agree will be admitted to the research inpatient unit at University of Pennsylvania or selected sites for the LDL kinetics study prior to vector administration. The LDL kinetic assessment will be performed using a primed constant infusion ...

Phase

1.27 miles

Learn More »

Timing of Coronary Artery Bypass Surgery Among Patients With Acute Coronary Syndromes Initially on Ticagrelor

Ticagrelor, a more potent P2Y12 inhibitor, has been shown to reduce major adverse cardiac events (MACE) in acute coronary syndromes (ACS). It is increasingly used as a first line therapy in ACS. However, more potent P2Y12 inhibition has been associated with increased bleeding. This may be of particular concern for ...

Phase N/A

1.27 miles

Learn More »

Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery

The tricuspid valve controls the flow of blood in your heart between the right ventricle and the right atrium. TR is a condition where the valve does not close fully when it is supposed to and blood can then leak back into the right atrium. When TR becomes severe, surgery ...

Phase N/A

1.27 miles

Learn More »